Haplotyping for disease association: a combinatorial approach

Giuseppe Lancia1, R Ravi, Romeo Rizzi

  • 1Dipartimento di Matematica e Informatica, University of Udine, Udine, Italy. lancia@dimi.uniud.it

Insights

This study addresses the challenge of inferring genetic "good" and "bad" haplotypes from population data to understand disease inheritance. A simple solution exists for this NP-complete problem if data meet a minimal requirement.

Area of Science:

  • Computational Biology
  • Genetics
  • Bioinformatics

Background:

  • Haplotyping is crucial for understanding genetic disease transmission.
  • Distinguishing between healthy and diseased individuals based on genotypes is complex.
  • Inferring haplotype contributions to disease status requires robust methods.

Purpose of the Study:

  • To formulate and solve a combinatorial problem for inferring disease-associated haplotypes.
  • To determine the computational complexity of haplotype inference for genetic diseases.
  • To identify conditions under which a simple solution for haplotyping is feasible.

Main Methods:

  • Formulation of a combinatorial problem based on population genotype data and disease status.
  • Analysis of the decision problem associated with inferring "good" and "bad" haplotypes.
  • Proof of NP-completeness for the general problem.
  • Development of a simple solution under specific data constraints.

Main Results:

  • The problem of inferring disease-related haplotypes is proven to be NP-complete.
  • A straightforward algorithm can solve the haplotyping problem.
  • The solution is contingent upon a minimal, weak data requirement.

Conclusions:

  • Despite the NP-complete nature of the general problem, efficient haplotyping is achievable.
  • The findings provide a practical approach for genetic disease analysis using population data.
  • This work contributes to the understanding of genotype-phenotype relationships in inherited diseases.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Probability Laws01:49

Probability Laws

Overview